At this point I think it is important to remember that Avita has currently has no debt and US $73.84M cash.
Avita currently has three clinical trials going on at the same time in the US as well as advancing the application for the approval of the RECELL system in Japan.
This I believe tells me that Avita is aggressively trying to bring on these new revenue streams as quickly as possible, and is the main focus of the company's spending at this early stage and why some people see the expenses as excessive currently.
I believe the current financial position will allow Avita to complete these trials and gain approval and increase the revenue streams greatly in US and Japan in the near future.
At this point I think it is important to remember that Avita has...
-
- There are more pages in this discussion • 596 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.63 |
Change
0.160(6.48%) |
Mkt cap ! $179.0M | |||
| Open | High | Low | Value | Volume |
| $2.54 | $2.64 | $2.54 | $874.2K | 336.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3056 | $2.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.63 | 4999 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVH (ASX) Chart |